Chromatin-associated lncRNA Malat1 regulates Th17 effector program and promotes intestinal inflammation
Ma, S.; Zhou, B.; Chen, N.; Luo, C.; Li, Y.; Patel, P. R.; Zheng, A.; Patel, S. A.; Hao, Y.; Chang, J. T.; Fu, X.; Huang, W. J. M.
Show abstract
Interleukin IL-17 cytokines are central regulators of mucosal homeostasis and disease. In mouse models of colonic tissue injury, IL-17A promotes epithelial barrier functions and restricts local inflammation. Here, we report that IL-17A production by the diverse T lymphocyte subsets is dynamically regulated at different stages of colitis pathogenesis. During the onset and peak of the disease, T{gamma}{delta}17 cells are the major IL-17A producers, while Th17 activity is temporally restricted by long non-coding RNA (lncRNA) Malat1. In response to IL-6 and TGF{beta} signaling, Malat1 is recruited to the Th17-specific cis-regulatory elements, CNS3 and CNS4, of the Il17a locus to fine-tune bivalent super-enhancer activities and repress local transcription. During the resolution phase of inflammation, Malat1 expression is down-regulated to enhance Th17 activities, allowing Th17 cells to emerge as the main producers of IL-17A in the colonic lamina propria. Genetic ablation of Malat1 potentiates IL-17A production in Th17 cells and improves disease outcomes in mouse models of colitis. These findings uncover a surprising role of a chromatin-associated lncRNA in regulating colonic Th17-specific responses to control the timing of inflammation resolution. Significance StatementT cells are critical modulators of mucosal barrier function and inflammation. The function of long-noncoding RNAs (lncRNAs) in T cells and their role in mucosal inflammation remain elusive. Here, we identify an essential role of the lncRNA Malat1 restricting transcription of the Il17a locus in Th17 cells encoding a cytokine implicated in epithelial barrier function post-injury. By controlling the activity of the bivalent super-enhancer at the Il17a locus, Malat1 regulates the timing of inflammation resolution in the intestine. The Malat1-Il17a pathway reveals new targets for combating mucosal diseases. Graphic Abstract O_FIG_DISPLAY_L [Figure 1] M_FIG_DISPLAY C_FIG_DISPLAY
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity 96%
- De novo synthesis and salvage pathway coordinately regulates polyamine homeostasis and determines T cell proliferation and function. 96%
- TET2 regulates early and late transitions in exhausted CD8+ T-cell differentiation and limits CAR T-cell function 95%
Similar papers in this journal
- A genome-wide screen in macrophages identifies new regulators of IFNγ-inducible MHCII that contribute to T cell activation 96%
- CXXC-finger protein 1 associates with FOXP3 to stabilize homeostasis and suppressive functions of regulatory T cells 96%
- Transposable elements regulate thymus development and function 96%
Similar papers in this journal
- Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism 97%
- Tuft cells mediate commensal remodeling of the small intestinal antimicrobial landscape 96%
- Homeostatic, repertoire and transcriptional relationships between colon T regulatory cell subsets 95%
Similar papers in this journal
- A20's Linear Ubiquitin Binding Motif Restrains Pathogenic Activation of TH17/22 cells and IL-22 Driven Enteritis 98%
- Distinct Colitis-Associated Macrophages Drive NOD2-Dependent Bacterial Sensing and Gut Homeostasis 97%
- Maintenance DNA methylation is essential for regulatory T cell development and stability of suppressive function 97%
Similar papers in this journal
- Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of Th17 immunity 96%
- The integrated stress response/eIF2α pathway controls cytokine production in tissue-resident memory CD4+ T cells 96%
- A distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.